Jump to content
Health NZ Taranaki Lab Manual

Tests:Phenytoin, Plasma: Difference between revisions

Department
Biochemistry
Tests:Phenytoin, Plasma
No edit summary
Updated method Alinity
 
(2 intermediate revisions by 2 users not shown)
Line 15: Line 15:
|Dilantin   
|Dilantin   
|-
|-
|Test Availability
|Availability
|Monday - Sunday, testing routinely available out of hours  
|Monday - Sunday, testing routinely available out of hours  
|-
|-
Line 27: Line 27:
== Specimen Requirements ==
== Specimen Requirements ==
|-
|-
|Specimen Type
|Specimen  
|Serum
|Serum


Line 50: Line 50:
== Aliquot Requirements ==
== Aliquot Requirements ==
|-
|-
|Sample Type
|Sample  
|
|
|-
|-
Line 69: Line 69:
|-
|-
|Test Method
|Test Method
|Roche Cobas 6000 using Roche Online reagents 
|Abbott Alinity c series analyser using Abbott reagents.
Enzymatic immunoassay
|-
|-
|Advanced Notice
|Advanced Notice
Line 82: Line 83:
| colspan="2" |Please supply last dosage details (time, date and dose) where possible, and collect sample immediately prior to next dose.   
| colspan="2" |Please supply last dosage details (time, date and dose) where possible, and collect sample immediately prior to next dose.   
|}
|}
{{DocMeta
| owner = Crossley1
| review_ping =
}}

Latest revision as of 12:22, 30 January 2026

Overview

Department Biochemistry
Test Code PHTN
Synonyms Dilantin 
Availability Monday - Sunday, testing routinely available out of hours
Turnaround Time 1 - 2 hours
Stability – Add test

Specimen Requirements

Specimen Serum

Plasma

Preferred 6 mL Plain Red-Top</span
Acceptable 6 mL Li-Hep Green-Top   
Unacceptable
Specimen Transportation Sample should be ideally collected immediately before next dose 
Paediatric Requirements 600 μL  Li-Hep Microtainer

Aliquot Requirements

Sample
Preferred Volume
Minimum Volume 1 mL 
Aliquot Transportation

Clinical Information

Reference Intervals Reference Range: 40 - 80 umol/L (For trough levels) 
Test Method Abbott Alinity c series analyser using Abbott reagents.

Enzymatic immunoassay

Advanced Notice
Patient Preparation

Comments

Please supply last dosage details (time, date and dose) where possible, and collect sample immediately prior to next dose. 
Owner Clair Crossley (Crossley1)
Last reviewed 30 Jan 2026
Next review 30 Jan 2027 OK